Healthcare

Johnson & Johnson is currently bolstering its healthcare portfolio with significant operational progress. The company has achieved a key regulatory...

Positive results from its dialysis subsidiary, Fresenius Medical Care (FMC), are providing a significant boost to the parent company, Fresenius...

The Swiss medical technology firm Ypsomed is entering a decisive period, marked by the conclusion of a major capital initiative...

The Danish pharmaceutical giant Novo Nordisk finds itself navigating a complex landscape of regulatory challenges and strategic realignments. Recent developments...

The therapeutic landscape for chronic inflammatory bowel diseases (IBD) is on the cusp of a significant shift. For years, the...

Axil Brands is broadening its hearing technology offerings with the introduction of a new product designed for both professional and...

Facing the impending loss of patent protection for its blockbuster drug Stelara in 2025, Johnson & Johnson has been under...

As Sangamo Therapeutics advances its gene therapy candidate for Fabry disease, investor focus is split between imminent regulatory milestones and...

Anixa Biosciences is intensifying its strategic focus on a pair of clinical-stage oncology assets. In a recent update, the company’s...

Talphera has achieved a significant enrollment milestone for its lead investigational drug, Niyad. The company announced that patient recruitment for...